Javascript must be enabled to continue!
Clinical Outcomes of Inferior Turbinate Reduction Surgery in Patients with Allergic Rhinitis: A Prospective Observational Study
View through CrossRef
Background: Allergic rhinitis is a chronic inflammatory disorder of the nasal mucosa characterized by nasal
obstruction, rhinorrhoea, sneezing, and itching, significantly affecting quality of life. Persistent nasal obstruction
secondary to inferior turbinate hypertrophy may remain refractory to medical treatment, necessitating surgical
intervention. Inferior turbinate reduction surgery aims to improve nasal airflow while preserving mucosal
function. The present study evaluated the clinical outcomes of inferior turbinate reduction surgery in patients with
allergic rhinitis.
Aim and Objective: To assess the efficacy of inferior turbinate reduction surgery in patients with allergic rhinitis
using postoperative symptomatic improvement, Total Nasal Symptom Score (TNSS), nasal airway patency, and
clinical outcomes.
Materials and Methods: A prospective observational study was conducted in the Department of
Otorhinolaryngology at Bundelkhand Medical College, Sagar, Madhya Pradesh, India, over 18 months
(September 2023–February 2025). Ninety patients with allergic rhinitis associated with inferior turbinate
hypertrophy and persistent symptoms despite medical therapy were included. Patients underwent submucosal
inferior turbinate reduction surgery and were followed up for 90 days postoperatively. Clinical evaluation included
TNSS assessment, anterior rhinoscopy, diagnostic nasal endoscopy, assessment of nasal airway patency, and
postoperative healing.
Results: Among the 90 participants, the majority belonged to the 18–25-year age group (43.3%), with a mean age
of 31.8 years, and males constituted 70% of the study population. Nasal obstruction was the most common
presenting symptom (90%), followed by rhinorrhoea (71%). Mean TNSS significantly decreased from 10.4
preoperatively to 5.4 at 90 days postoperatively (p<0.05), indicating substantial symptomatic improvement
following surgery. Postoperative follow-up demonstrated satisfactory healing and improved nasal airway patency.
Crusting was the most common postoperative complaint and resolved with conservative management, while no
cases of severe hemorrhage or empty nose syndrome were observed.
Conclusion: Inferior turbinate reduction surgery was associated with significant improvement in symptom
severity, reduction in nasal obstruction, and favorable postoperative outcomes with minimal complications among
patients with allergic rhinitis. The findings support submucosal inferior turbinate reduction as a safe and effective
treatment option for selected patients with persistent symptoms despite medical therapy.
Dr. Yashwant Research Labs Pvt. Ltd.
Title: Clinical Outcomes of Inferior Turbinate Reduction Surgery in Patients with Allergic Rhinitis: A Prospective Observational Study
Description:
Background: Allergic rhinitis is a chronic inflammatory disorder of the nasal mucosa characterized by nasal
obstruction, rhinorrhoea, sneezing, and itching, significantly affecting quality of life.
Persistent nasal obstruction
secondary to inferior turbinate hypertrophy may remain refractory to medical treatment, necessitating surgical
intervention.
Inferior turbinate reduction surgery aims to improve nasal airflow while preserving mucosal
function.
The present study evaluated the clinical outcomes of inferior turbinate reduction surgery in patients with
allergic rhinitis.
Aim and Objective: To assess the efficacy of inferior turbinate reduction surgery in patients with allergic rhinitis
using postoperative symptomatic improvement, Total Nasal Symptom Score (TNSS), nasal airway patency, and
clinical outcomes.
Materials and Methods: A prospective observational study was conducted in the Department of
Otorhinolaryngology at Bundelkhand Medical College, Sagar, Madhya Pradesh, India, over 18 months
(September 2023–February 2025).
Ninety patients with allergic rhinitis associated with inferior turbinate
hypertrophy and persistent symptoms despite medical therapy were included.
Patients underwent submucosal
inferior turbinate reduction surgery and were followed up for 90 days postoperatively.
Clinical evaluation included
TNSS assessment, anterior rhinoscopy, diagnostic nasal endoscopy, assessment of nasal airway patency, and
postoperative healing.
Results: Among the 90 participants, the majority belonged to the 18–25-year age group (43.
3%), with a mean age
of 31.
8 years, and males constituted 70% of the study population.
Nasal obstruction was the most common
presenting symptom (90%), followed by rhinorrhoea (71%).
Mean TNSS significantly decreased from 10.
4
preoperatively to 5.
4 at 90 days postoperatively (p<0.
05), indicating substantial symptomatic improvement
following surgery.
Postoperative follow-up demonstrated satisfactory healing and improved nasal airway patency.
Crusting was the most common postoperative complaint and resolved with conservative management, while no
cases of severe hemorrhage or empty nose syndrome were observed.
Conclusion: Inferior turbinate reduction surgery was associated with significant improvement in symptom
severity, reduction in nasal obstruction, and favorable postoperative outcomes with minimal complications among
patients with allergic rhinitis.
The findings support submucosal inferior turbinate reduction as a safe and effective
treatment option for selected patients with persistent symptoms despite medical therapy.
Related Results
Allergic Rhinitis
Allergic Rhinitis
Importance
Allergic rhinitis affects an estimated 15% of the US population (approximately 50 million individuals) and is associated with the presence of asthma,...
Rhinitis-Respect your nose
Rhinitis-Respect your nose
We all know the functions of nose i.e. breathing and smell. The outcome of breathing is to ventilate the lungs and we also know that there is lung compliance which reflects its eff...
Persistent rhinitis – allergic or nonallergic?
Persistent rhinitis – allergic or nonallergic?
SummaryAlthough rhinitis has been classified as being either allergic, noninfectious, or ‘‘other forms’’ (nonallergic noninfectious), these categories lack strict classification cr...
Allergic rhinitis, part of the allergic respiratory syndrome
Allergic rhinitis, part of the allergic respiratory syndrome
Introduction. Diseases associated with immunoglobulin E hypersensitivity,
such as allergic rhinitis, may have different clinical expressions. Patients
with allergic rhinitis ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma
Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma
SummaryBackground
Allergic rhinitis and asthma comorbidity is supported by both the similar underlying pathogenesis and immunologic mechanisms. The aim of this study was to v...
Quality of Life in Allergic Rhinitis and Asthma
Quality of Life in Allergic Rhinitis and Asthma
Abstract
Quality of life has been found to be impaired both in patients with asthma and in patients with allergic rhinitis, but the relative burden of these disea...
Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors
Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors
Background: Subjects with allergic rhinitis but no clinical evidence of asthma have greater bronchial hyperresponsiveness (BHR), and several factors have been implicated as its de...

